Enrolling by invitation

Virtual Reality Device for Pain and Anxiety Management During Labor

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Virtual Reality Hypnosis for Labor Pain and Anxiety Management

Device
Who is being recruted

Agnosia+8

+ Anxiety Disorders

+ Mental Disorders

From 18 to 45 Years
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: May 2025
See protocol details

Summary

Principal SponsorUniversity Tunis El Manar
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2025

Actual date on which the first participant was enrolled.

This study is exploring the use of a virtual reality hypnosis device called HypnoVR to help manage pain and anxiety for women during childbirth. It focuses on women who are in the early and active stages of labor and aims to see if this technology can offer relief without using medication. The study is important as it could provide a new way to support women during labor, potentially making the experience less stressful and painful by using VR technology, which is a non-drug approach. Participants in the study are divided into two groups. One group uses the HypnoVR device, which they experience through virtual reality, while the other group receives the usual care given during labor. The study measures how effective HypnoVR is by looking at changes in pain and anxiety levels using specific scales before and after the intervention. It also checks other factors such as the mother's heart rate and blood pressure, the frequency and strength of contractions, the baby's heart rate, and how satisfied the mothers feel after the birth. This approach ensures a thorough understanding of how HypnoVR might impact the labor process and overall experience.

Official TitleEffectiveness of Virtual Reality (HypnoVR) in Pain and Anxiety Management During Labor: Multicenter Randomized Controlled Trial
Principal SponsorUniversity Tunis El Manar
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

70 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AgnosiaAnxiety DisordersMental DisordersNervous System DiseasesNeurologic ManifestationsPainPerceptual DisordersSigns and SymptomsPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsLabor Pain

Criteria

Inclusion Criteria: Participants must meet all of the following criteria to be eligible for inclusion in the study: * Female participants aged between 18 and 45 years * Primiparous or multiparous * Singleton pregnancy * Cephalic (vertex) presentation * Gestational age between 37 and 41 completed weeks * Admitted in spontaneous (uninduced) labor * Low-risk pregnancy with no obstetric complications (e.g., no preeclampsia, gestational diabetes, or intrauterine growth restriction) * Spontaneous and uneventful course of pregnancy * At least four documented prenatal care visits during pregnancy * Expressed desire for vaginal delivery * Provided written informed consent to participate in the study Exclusion Criteria: Participants will be excluded from the study if they meet any of the following criteria: * History of any psychiatric disorder (e.g., anxiety, depression, bipolar disorder, psychosis, delirium) organic brain disease, or cognitive/developmental disorders) * History of seizures or epilepsy * Any degree of hearing impairment * Any visual impairment * History of face, neck, or head injuries that may interfere with the use of virtual reality equipment * History of motion sickness or vestibular disorders (e.g., dizziness, vertigo) * Chronic pain conditions or frequent migraines * History of claustrophobia * High-risk pregnancy (e.g., fetal growth restriction, placenta previa, or other significant maternal-fetal complications) * Known fetal anomalies or placental abnormalities * Labor pain not attributed to uterine contractions * Induced labor (medically or pharmacologically initiated)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients in the intervention arm received standard obstetric care in addition to a virtual reality hypnosis session using the HypnoVR headset. The VR session, administered during the latent or active phase of labor, included immersive audiovisual content designed to promote relaxation, reduce anxiety, and alleviate pain through guided breathing and hypnotic suggestions

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Ben Arous regional Hospital

Ben Arous, TunisiaOpen Ben Arous regional Hospital in Google Maps
Enrolling by invitationOne Study Center